Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T16:10:53.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T16:15:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates the study details are currently unavailable due to permission or server issues.
    Difference
    19%
    Check dated 2026-09-19T20:50:42.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    A 2015 U.S. NIH Grant/Contract note and the rheumatoid arthritis topic were added, along with a related topics link to MedlinePlus Genetics. The revision label was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T18:08:49.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page no longer lists the disease tag 'Rheumatoid arthritis' and the related topics section (MedlinePlus Genetics), removing key disease-specific context and external references.
    Difference
    0.1%
    Check dated 2026-08-22T13:31:42.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.6.4 to v3.6.5, representing a small update to the page's versioning descriptor without altering the displayed study details.
    Difference
    0.0%
    Check dated 2026-08-08T04:37:05.000Z thumbnail image

Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.